Abstract
Objective
Developmental dysplasia of the hip (DDH) is a complicated skeletal disease ranging from subluxation to complete dislocation of the hip as a result of insufficient development of the acetabulum and femur. To date, numerous genes such as C-X3-C motif chemokine receptor 1 (CX3CR1), ubiquinol-cytochrome c reductase complex assembly factor 1 (UQCC1) and growth/differentiation factor 5 (GDF5), have been investigated to elucidate the underlying genetic etiology. Turkish population is one of the communities where DDH patients frequently observed, but almost no study has been conducted to elucidate the genetic etiology. In our study, we aimed to investigate the polymorphism of CX3CR1 rs3732378 and UQCC1 rs6060373, which have been shown to be associated with DDH in different populations. In addition, we aimed to investigate the BMP-2 rs235768 polymorphism which has not been investigated in the etiology of DDH.
Methods
Overall, 168 subjects (68 participants in the patient group, 100 participants in the control group) were investigated. The participants with following evidence and symptoms were excluded from the two groups: any systemic syndrome, another congenital anomaly, hereditary diseases, breech presentation, history of oligohydramnios, swaddling and high birth weight (> 4000 g). 3 single-nucleotide polymorphisms (SNP) were examined by qRT-PCR method.
Results
For CX3CR1 rs3732378 polymorphism, significant differences were observed in genotypes and allele frequencies (p < 0.0001). This condition was associated with a 12-fold increased risk in recessive modeling and 75-fold increased risk in dominant modeling. There was no significant relationship between DDH and the other two polymorphisms.
Conclusions
Our work is the first study to investigate DDH and genetic polymorphisms in Turkish population where DDH is observed quite frequently. It is also the first study to investigate the relationship between BMP-2 rs235768 polymorphism and DDH. Our study revealed a clear relationship between CX3CR1 rs3732378 polymorphism and DDH in Turkish population.
Similar content being viewed by others
References
Pollet, V., Percy, V., & Prior, H. J. (2017). Relative risk and incidence for developmental dysplasia of the hip. Journal of Pediatrics, 181, 202–207. https://doi.org/10.1016/j.jpeds.2016.10.017.
McCarthy, J. J., Scoles, P. V., & MacEwen, G. D. (2005). Developmental dysplasia of the hip (DDH). Curr Orthop, 19, 223–230. https://doi.org/10.1016/j.cuor.2005.05.007.
Dezateux, C., & Rosendahl, K. (2007). Developmental dysplasia of the hip. Lancet, 369, 1541–1552. https://doi.org/10.1016/S0140-6736(07)60710-7.
Ayanoglu, T., Ataoglu, M. B., Tokgöz, N., et al. (2019). Assessing the risk of asymptomatic dysplasia in parents of children with developmental hip dysplasia. Acta Orthop Traumatol Turc. https://doi.org/10.1016/j.aott.2019.07.002.
Basit, S., Hannan, M. A., & Khoshhal, K. I. (2016). Developmental dysplasia of the hip: usefulness of next generation genomic tools for characterizing the underlying genes–a mini review. Clinical Genetics, 90, 16–20. https://doi.org/10.1111/cge.12755.
Zamborsky, R., Kokavec, M., Harsanyi, S., et al. (2019). Developmental dysplasia of hip: perspectives in genetic screening. Med Sci, 7, 59. https://doi.org/10.3390/medsci7040059.
Yan, W., Hao, Z., Tang, S., et al. (2019). A genome-wide association study identifies new genes associated with developmental dysplasia of the hip. Clinical Genetics, 95, 345–355. https://doi.org/10.1111/cge.13483.
Feldman, G. J., Parvizi, J., Levenstien, M., et al. (2013). Developmental dysplasia of the hip: linkage mapping and whole exome sequencing identify a shared variant in CX3CR1 in all affected members of a large multigeneration family. Journal of Bone and Mineral Research, 28, 2540–2549. https://doi.org/10.1002/jbmr.1999.
Hatzikotoulas, K., Roposch, A., Shah, K. M., et al. (2018). Genome-wide association study of developmental dysplasia of the hip identifies an association with GDF5. Commun Biol, 1, 56. https://doi.org/10.1038/s42003-018-0052-4.
El, Jashi R., Gustafson, M. B., Jakobsen, M. B., et al. (2017). The association between gender and familial prevalence of hip dysplasia in danish patients. HIP Int, 27, 299–304. https://doi.org/10.5301/hipint.5000461.
Sun, Y., You, Y., Dai, K., et al. (2019). Genetic variant of WIF1 gene is functionally associated with developmental dysplasia of the hip in Han Chinese population. Sci Rep, 9, 285. https://doi.org/10.1038/s41598-018-36532-8.
Feldman, G. J., Parvizi, J., Sawan, H., et al. (2014). Linkage mapping and whole exome sequencing identify a shared variant in CX3CR1 in a large multi-generation family. Journal of Arthroplasty, 29, 238–241. https://doi.org/10.1016/j.arth.2014.05.014.
Sun, Y., Wang, C., Hao, Z., et al. (2015). A common variant of ubiquinol-cytochrome c reductase complex is associated with DDH. PLoS ONE, 10, e0120212. https://doi.org/10.1371/journal.pone.0120212.
Samee, M., Kasugai, S., Kondo, H., et al. (2008). BMP-2 and VEGF transfection to human periosteal cells enhances osteoblast differentiation and bone formation. J Pharmacol Sci, 108, 18–31.
Mi, M., Jin, H., Wang, B., et al. (2013). Chondrocyte BMP2 signaling plays an essential role in bone fracture healing. Gene, 512, 211–218. https://doi.org/10.1016/j.gene.2012.09.130.
Kugimiya, F., Kawaguchi, H., Kamekura, S., et al. (2005). Involvement of endogenous bone BMP 2 and BMP6 in bone formation. Journal of Biological Chemistry, 280, 35704–35712.
Lowery, J. W., & Rosen, V. (2018). The BMP pathway and its inhibitors in the skeleton. Physiological Reviews, 98, 2431–2452. https://doi.org/10.1152/physrev.00028.2017.
Goldring, M. B., Tsuchimochi, K., & Ijiri, K. (2006). The control of chondrogenesis. Journal of Cellular Biochemistry, 97, 33–44. https://doi.org/10.1002/jcb.20652.
Lee, M., Lee, Y., Song, J., et al. (2018). Tissue-specific Role of CX 3 CR1 expressing immune cells and their relationships with human disease. Immune Netw. https://doi.org/10.4110/in.2018.18.e5.
Qiao, L., Dai, J., Yan, W., et al. (2017). Variants rs3732378 and rs3732379 of gene CX3CR1 are not associated with developmental dysplasia of the hip in Han Chinese population. Int J Clin Exp Pathol, 10, 2095–2099.
Feldman, G., Offemaria, A., Sawan, H., et al. (2017). A murine model for developmental dysplasia of the hip: ablation of CX3CR1 affects acetabular morphology and gait. J Transl Med, 15, 233. https://doi.org/10.1186/s12967-017-1335-0.
Swarup, I., Penny, C. L., & Dodwell, E. R. (2018). Developmental dysplasia of the hip: an update on diagnosis and management from birth to 6 months. Current Opinion in Pediatrics, 30, 84–92. https://doi.org/10.1097/MOP.0000000000000574.
Shu, B., Zhang, M., Xie, R., et al. (2011). BMP2, but not BMP4, is crucial for chondrocyte proliferation and maturation during endochondral bone development. Journal of Cell Science, 124, 3428–3440. https://doi.org/10.1242/jcs.083659.
Tan, T. Y., Gonzaga-Jauregui, C., Bhoj, E. J., et al. (2017). Monoallelic BMP2 variants predicted to result in haploinsufficiency cause craniofacial, skeletal, and cardiac features overlapping those of 20p12 deletions. American Journal of Human Genetics, 101, 985–994. https://doi.org/10.1016/j.ajhg.2017.10.006.
McBride, S. H., McKenzie, J. A., Bedrick, B. S., et al. (2014). Long bone structure and strength depend on BMP2 from osteoblasts and osteocytes, but not vascular endothelial cells. PLoS ONE, 9, e96862. https://doi.org/10.1371/journal.pone.0096862.
Li, J., Zhang, Y., Ren, Y., et al. (2014). Uniaxial cyclic stretch promotes osteogenic differentiation and synthesis of BMP2 in the C3H10T1/2 cells with BMP2 gene variant of rs2273073 (T/G). PLoS ONE, 9, e106598. https://doi.org/10.1371/journal.pone.0106598.
Usategui-Martín, R., Vega, G., Abad-Manteca, L., et al. (2018). Role of bone morphogenetic protein 2 polymorphisms in bone mineral density after the start of treatment with atorvastatin. Basic & Clinical Pharmacology & Toxicology, 123, 766–769. https://doi.org/10.1111/bcpt.13086.
Deng, F.-Y., Dong, S.-S., Xu, X.-H., et al. (2013). Genome-wide association study identified UQCC locus for spine bone size in humans. Bone, 53, 129–133. https://doi.org/10.1016/j.bone.2012.11.028.
Sanna, S., Jackson, A. U., Nagaraja, R., et al. (2008). Common variants in the GDF5-UQCC region are associated with variation in human height. Nature Genetics, 40, 198–203. https://doi.org/10.1038/ng.74.
Cristino, S., Piacentini, A., Manferdini, C., et al. (2008). Expression of CXC chemokines and their receptors is modulated during chondrogenic differentiation of human mesenchymal stem cells grown in three-dimensional scaffold: evidence in native cartilage. Tissue Engineering Part A, 14, 97–105. https://doi.org/10.1089/ten.a.2007.0121.
Hoshino, A., Ueha, S., Hanada, S., et al. (2013). Roles of chemokine receptor CX3CR1 in maintaining murine bone homeostasis through the regulation of both osteoblasts and osteoclasts. Journal of Cell Science, 126, 1032–1045. https://doi.org/10.1242/jcs.113910.
Li, L., Wang, X., Zhao, Q., et al. (2017). CX3CR1 polymorphisms associated with an increased risk of developmental dysplasia of the hip in human. Journal of Orthopaedic Research, 35, 377–380. https://doi.org/10.1002/jor.23294.
Zhu, L.-Q., Su, G.-H., Dai, J., et al. (2019). Whole genome sequencing of pairwise human subjects reveals DNA mutations specific to developmental dysplasia of the hip. Genomics, 111, 320–326. https://doi.org/10.1016/j.ygeno.2018.02.006.
Harsanyi, S., Zamborsky, R., Kokavec, M., & Danisovic, L. (2020). Genetics of developmental dysplasia of the hip. Eur J Med Genet. https://doi.org/10.1016/j.ejmg.2020.103990.
Harsanyi, S., Zamborsky, R., Krajciova, L., et al. (2020). Developmental dysplasia of the hip: a review of etiopathogenesis, risk factors, and genetic aspects. Medicina, 56(4), 153. https://doi.org/10.3390/medicina56040153.
Kenanidis, E., Gkekas, N. K., Karasmani, A., et al. (2020). Genetic predisposition to developmental dysplasia of the hip. Journal of Arthroplasty, 35, 291–300. https://doi.org/10.1016/j.arth.2019.08.031.
Acknowledgements
We thank Ozlem Oz, Ismail Koyuncu, Celal Bozkurt for their contributions to the study.
Funding
Funding was provided by Harran Üniversitesi (Grant No. 18239).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflicting interest on this work.
Ethical standard statement
This article does not contain any studies with human or animal subjects performed by the any of the authors.
Informed consent
For this type of study informed consent is not required.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Gumus, E., Temiz, E., Sarikaya, B. et al. The Association Between BMP-2, UQCC1 and CX3CR1 Polymorphisms and the Risk of Developmental Dysplasia of the Hip. JOIO 55, 169–175 (2021). https://doi.org/10.1007/s43465-020-00235-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s43465-020-00235-y